Received Sep 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (ABRYSVO) | PFIZER\WYETH | 1 | LN5489 | LA |
red bumps; rash; possible allergic reaction; This is a spontaneous report received from a Pharmacist from medical information team, Program ID. A 73-year-old female patient received rsv vaccine prot.subunit pref 2v (ABRYSVO), on 09Sep2025 as dose 1, single (Lot number: LN5489, Expiration Date: 31Oct2025) at the age of 73 years, in left deltoid for immunisation. The patient's relevant medical history included: "blood pressure" (unspecified if ongoing); "fluid overload" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN taken for blood pressure abnormal (ongoing); TORSEMIDE taken for hypervolaemia (ongoing). The following information was reported: RASH PAPULAR (non-serious), outcome "unknown", described as "red bumps"; RASH (non-serious), outcome "unknown"; HYPERSENSITIVITY (non-serious), outcome "unknown", described as "possible allergic reaction". Additional information: According to the patient the rash only started a few days ago, the red bumps occurred before the rash occurred.
Medical History/Concurrent Conditions: Blood pressure abnormal; Fluid overload
LOSARTAN; TORSEMIDE